Skip to main content
Terug
GENB logo

Generate Biomedicines, Inc.

Datakwaliteit: 100%
GENB
NASDAQ Financial Services Asset Management
€ 12,52
▲ € 0,25 (2,04%)
Marktkapitalisatie: 1,60B
Dagbereik
€ 12,09 € 12,76
52-Weeksbereik
€ 11,00 € 15,32
Volume
305.122
50D / 200D Gem.
€ 12,26 / € 12,26
Vorige Slotkoers
€ 12,27

Koershistorie

Financiële Trends

Sectorvergelijking

vs Financial Services sector mediaan (854 peers)

Metriek Aandeel Sector Mediaan
P/E -7,9 10,3
P/B 1,1
ROE % 11,7
Net Margin % -637,0 16,8
Rev Growth 5Y % 11,7
D/E 0,5

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Geen toekomstige schattingen beschikbaar

Belangrijkste Punten

Negative free cash flow of -204,13M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)55,89%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROICN/A
Net Margin-636,99%
Op. Margin-737,04%

Veiligheid

Debt / Equity
N/A
Current Ratio2,85
Interest Coverage-206,92

Waardering

P/E Ratio
-7,85
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 55,89% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 31,89M Net Income (TTM) -203,15M
ROE N/A ROA -61,53%
Gross Margin 100,00% Operating Margin -737,04%
Net Margin -636,99% Free Cash Flow (TTM) -204,13M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2,85
Interest Coverage -206,92 Dividend Yield 0,00%
Valuation
P/E Ratio -7,85 P/B Ratio N/A
P/S Ratio 50,03 PEG Ratio -0,02
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 1,60B Enterprise Value 1,54B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024
Revenue 31,89M 20,46M
Net Income -203,15M -173,77M
EPS (Diluted) -4,98 -1,68
Gross Profit 31,89M 20,46M
Operating Income -235,07M -196,94M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024
Total Assets 330,18M 518,26M
Total Liabilities 953,38M 953,35M
Shareholders' Equity -615,97M -434,52M
Total Debt 68,53M 76,97M
Cash & Equivalents 121,65M 176,27M
Current Assets 234,37M 407,49M
Current Liabilities 82,20M 86,63M